Rachel Koldej - Concepedia

Author

Rachel Koldej

The Royal Melbourne Hospital ORCID

Also Known As

Koldej, Rachel, R Koldej, R. Koldej, R. M. Koldej, R.M. Koldej, Rachel Koldej, Rachel M Koldej, Rachel M. Koldej

114

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

The Royal Melbourne Hospital The University of Melbourne Peter MacCallum Cancer Centre Walter and Eliza Hall Institute of Medical Research The University of Adelaide

About

Rachel Koldej is an author at The Royal Melbourne Hospital specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	204
2	Cell Biology	3	3	74
3	Engineering	1	1	43
4	Blood Transplantation	1	1	14
5	Cellular Therapies	1	1	14

Rachel Koldej

Publications

929

Citations

H-Index

Page 1

	Year	Citations
Preclinical safety and efficacy of an anti–HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor Orit Wolstein, Maureen Boyd, Michelle Millington, Molecular Therapy — Methods & Clinical Development	2014	73
miRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage Stanley S. Stylli, Alexios A. Adamides, Rachel Koldej, Journal of neurosurgery Objective MicrornasPathologyCerebral VasospasmCerebral Vascular RegulationNeurovascular Disease	2016	69
Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy Sara Mastaglio, Eric Wong, Travis Perera, Blood Advances	2018	67
Single‐dose lentiviral gene transfer for lifetime airway gene expression Alice G. Stocker, Karlea L. Kremer, Rachel Koldej, The Journal of Gene Medicine	2009	66
Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production Rachel Koldej, Patricia Cmielewski, Alice G. Stocker, The Journal of Gene Medicine	2005	57
CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study Adrian Minson, Nada Hamad, Chan Y. Cheah, Blood	2023	54
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in <i>BRAF</i> V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study Lavinia Tan, Ben Tran, Jeanne Tie, Clinical Cancer Research	2023	45
Serum microRNA is a biomarker for post-operative monitoring in glioma Andrew Morokoff, Jordan Jones, Hong Nguyen, Journal of Neuro-Oncology EngineeringPathologyHigh-grade GliomasGliomaTumor Biology	2020	43
Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells Rachel E. Cooke, Kylie M. Quinn, Hang Quach, Frontiers in Immunology	2020	38
Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA. Donald S. Anson, Chantelle McIntyre, Belinda J. Thomas, Genetic Vaccines and Therapy	2007	35

Page 1